Cite
First-Line Treatment of Waldenström's Macroglobulinaemia: Considerations Based on the Dutch National Guideline.
MLA
Amaador, Karima, et al. “First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline.” Hemato, vol. 3, no. 4, Dec. 2022, pp. 704–17. EBSCOhost, https://doi.org/10.3390/hemato3040047.
APA
Amaador, K., Kersten, M. J., Visser, H. P. J., Nieuwenhuizen, L., Schop, R. F. J., Chamuleau, M. E. D., Velders, G. A., Minnema, M. C., & Vos, J. M. I. (2022). First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline. Hemato, 3(4), 704–717. https://doi.org/10.3390/hemato3040047
Chicago
Amaador, Karima, Marie José Kersten, Hein P. J. Visser, Laurens Nieuwenhuizen, Roelandt F. J. Schop, Martine E. D. Chamuleau, Gerjo A. Velders, Monique C. Minnema, and Josephine Mathilde Iris Vos. 2022. “First-Line Treatment of Waldenström’s Macroglobulinaemia: Considerations Based on the Dutch National Guideline.” Hemato 3 (4): 704–17. doi:10.3390/hemato3040047.